The National Association of Realtors (NAR) this morning released its data on pending home sales in December. The index fell 4.3% from a downwardly revised 106.3 in November to 101.7, and it is 6.9% higher than in December 2011 when the index reading was 95.1. The consensus estimate called for a slight decrease of 0.3% in pending sales. The index reflects signed contracts, not sales closings. An index reading of 100 equals the average level of contract signings during 2001.
The NAR’s chief economist noted:
The supply limitation appears to be the main factor holding back contract signings in the past month. Still, contract activity has risen for 20 straight months on a year-over-year basis. … We expect a seasonal rise of inventory in the spring to help, but a seller’s market may be developing. Much of the West is already a seller’s market for homes priced under a million dollars, but conditions are much more balanced in the Northeast.
Pending sales fell most in the West — down 8.2% compared with November. In the Midwest sales improved 0.9% from November, and sales in the South declined 4.5%. Pending sales in the Northeast fell 5.4% month-over-month, but remained 8.4% higher than a year ago.
The NAR noted that existing home sales rose 9% in 2012, and the group expects a similar rise in sales this year.
Smart Investors Are Quietly Loading Up on These “Dividend Legends”
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats.
There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside.
If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
By providing your email address, you agree to receive communications from us regarding website updates and other offerings that may be of interest to you.
You have the option to opt-out of these emails at any moment. For more information, please review our Disclaimer and Terms of Use.